Malaria treatment study. https://t.co/jPxh7XaZYi
RT @CDC_EIDjournal: Genomics of recrudescent p.malariae after directly observed treatment, #EIDjournal, https://t.co/hjcho4eyzl https://t.c…
Genomics of recrudescent p.malariae after directly observed treatment, #EIDjournal, https://t.co/hjcho4eyzl https://t.co/oQotsQvL4s
RT @ricprice99: Artemether-Lumefantrine is not ideal treatment for P. malariae https://t.co/DeDYW5G5gt
Artemether-Lumefantrine is not ideal treatment for P. malariae https://t.co/DeDYW5G5gt
RT @MalariaUnit: Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine. https://t.co/0…
Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine. https://t.co/0RfQdrM8r8
Suboptimal treatment for P malaria https://t.co/MsulnPuuhK
Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine. https://t.co/3FYdzUKNKV
RT @IDPractitioner: 3-day artemether/lumefantrine regimen is suboptimal for P. malariae because of its long asexual lifecycle https://t.co/…
Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine https://t.co/8WKZGLnMPD @CDCgov